跳至主要内容
临床试验/CTRI/2019/04/018796
CTRI/2019/04/018796招募中未知

His Bundle Pacing Registry - HBP Registry

St Jude Medical India Pvt Ltd Abbott0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Subjects must meet the following inclusion criteria for enrollment in the registry.
  • 1. Scheduled for implantation of a de novo Abbott pacemaker, defibrillator, or CRT-P/D device with a pacing lead located at the His bundle according to the clinical siteâ??s routine care
  • 2. At least 18 years of age
  • 3. Willing and able to comply with the prescribed follow-up tests and schedule of evaluations
  • 4. Provided written informed consent prior to any registry-related procedures

排除标准

  • Subjects will be excluded from enrollment if any of the exclusion criteria is met below.
  • 1. History of tricuspid valve repair or replacement
  • 2. Currently participating in another clinical study with an active treatment arm and belong to the active arm
  • 3. Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigatorâ??s opinion, could limit the subjectâ??s ability to participate in the registry or to comply with follow-up requirements, or impact the scientific soundness of the registry results
  • 4. Previous failed HBP implant
  • 5. Life expectancy of less than 6 months
  • 6. Known contraindication for an HBP implant (i.e. ongoing infection, known inclusion of the subclavian vein, etc.)

研究者

发起方
St Jude Medical India Pvt Ltd Abbott

相似试验

招募中
不适用
Registry of Conduction System Pacing
JPRN-UMIN000040583The University of Tokyo Hospital100
已完成
不适用
Observational Bavarian Health Insurance RegistryI70I70.8I70.9I67.2I25.1I25.2I25.19I20.0I20.8I20.9I21I21.4I21.9I63I66I65I70.2Unstable anginaAtherosclerosis of other arteriesGeneralized and unspecified atherosclerosisAtherosclerotic heart diseaseOld myocardial infarctionOther forms of angina pectorisAngina pectoris, unspecifiedAcute subendocardial myocardial infarctionAcute myocardial infarction, unspecifiedOcclusion and stenosis of cerebral arteries, not resulting in cerebral infarctionCerebral atherosclerosisOcclusion and stenosis of precerebral arteries, not resulting in cerebral infarctionAtherosclerosis of arteries of extremitiesCerebral infarctionAcute myocardial infarctionAtherosclerosis
DRKS00024016Deutsches Herzzentrum München der Technischen Universität1,300,000
进行中(未招募)
不适用
SPARK Registry (High Power Registry)Ventricular Tachycardia, Heart Failure
JPRN-jRCT1042200049Goya Masahiko400
进行中(未招募)
1 期
PROLONGSTEM is a long term follow-up study of all the patients who have received at least one infusion of HepaStemThis study will include all patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HALPC during a previous interventional clinical study conducted by Promethera Biosciences or Promethera Therapeutics including patients suffering from urea cycle disorders (UCD), Crigler-Najjar (CN) and Fibroinflammatory liver diseases.MedDRA version: 20.1Level: LLTClassification code: 10021601Term: Inborn error of metabolism NOS Class: 10010331MedDRA version: 20.0Level: LLTClassification code: 10008954Term: Chronic liver disease and cirrhosis Class: 10019805MedDRA version: 21.1Level: LLTClassification code: 10013373Term: Disorders of urea cycle metabolism Class: 10010331MedDRA version: 20.1Level: LLTClassification code: 10049844Term: Acute liver failure Class: 10019805
CTIS2022-500251-22-00Cellaïon SA68
进行中(未招募)
1 期
PROLONGSTEM is a long term follow-up study of all the patients who have received at least one infusion of HepaStemThis study will include all patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Biosciences including patients suffering from urea cycle disorders (UCD), Crigler-Najjar (CN) and Fibro-inflammatory liver diseasesMedDRA version: 20.1 Level: LLT Classification code 10021601 Term: Inborn error of metabolism NOS System Organ Class: 100000004850MedDRA version: 20.0 Level: LLT Classification code 10008954 Term: Chronic liver disease and cirrhosis System Organ Class: 100000004871MedDRA version: 20.1 Level: LLT Classification code 10049844 Term: Acute liver failure System Organ Class: 100000004871MedDRA version: 20.1 Level: LLT Classification code 10013373 Term: Disorders of urea cycle metabolism System Organ Class: 200000003094
EUCTR2017-003989-27-GBPromethera Biosciences22